• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌萎缩侧索硬化症基因(ATXN3)的转录本多样性不受外显子或侧翼内含子区域 SNPs 的直接影响。

Transcript diversity of Machado-Joseph disease gene (ATXN3) is not directly determined by SNPs in exonic or flanking intronic regions.

机构信息

Institute for Molecular and Cell Biology (IBMC), University of Porto, 4150, Porto, Portugal.

出版信息

J Mol Neurosci. 2013 Mar;49(3):539-43. doi: 10.1007/s12031-012-9832-3. Epub 2012 Jun 16.

DOI:10.1007/s12031-012-9832-3
PMID:22706685
Abstract

Alternative splicing (AS) of pre-mRNA is an important regulatory mechanism that enables one gene to produce multiple mature transcripts and, therefore, multiple protein isoforms. Besides the information content of core splicing signals, additional cis-regulatory elements (splicing enhancers and silencers) are needed to precisely define exons. AS is well documented in ATXN3 gene, which encodes for ataxin-3 and, when mutated, is responsible for Machado-Joseph disease (MJD). By studying MJD patients and controls, we have previously identified 56 alternative transcript variants for this gene; some were predicted to encode "protective" ataxin-3 isoforms, making then pertinent to understand AS regulation. The present study aims to investigate the relationship between variation in ATXN3 cis-regulatory motifs and AS variants found for each individual. We have sequenced exonic and flanking intronic ATXN3 regions, in genomic DNA from MJD patients and controls previously studied. None of the 10 single nucleotide polymorphisms (SNPs) that were found was located in core splicing signals. In silico analysis showed those SNPs implied losses and gains of recognition motifs for splicing factors. Each particular allele was not directly reflected in alterations of the resulting splicing variants, indicating that AS cannot be determined solely by these cis-elements, but should result from a more complex mode of regulation.

摘要

选择性剪接(AS)的前体 mRNA 是一种重要的调控机制,它使一个基因能够产生多个成熟的转录本,从而产生多个蛋白质同工型。除了核心剪接信号的信息含量外,还需要额外的顺式调控元件(剪接增强子和沉默子)来精确定义外显子。ATXN3 基因中的 AS 得到了很好的证明,该基因编码共济失调蛋白-3,当发生突变时,会导致 Machado-Joseph 病(MJD)。通过研究 MJD 患者和对照者,我们之前已经鉴定出该基因的 56 种选择性转录变体;其中一些被预测为编码“保护性”共济失调蛋白-3同工型,因此了解 AS 调控机制很重要。本研究旨在探讨 ATXN3 顺式调控元件变异与每个个体发现的 AS 变体之间的关系。我们对之前研究过的 MJD 患者和对照者的基因组 DNA 中的 ATXN3 外显子和侧翼内含子区域进行了测序。发现的 10 个单核苷酸多态性(SNP)中没有一个位于核心剪接信号中。计算机分析表明,这些 SNP 暗示了剪接因子识别基序的丢失和获得。每个特定的等位基因并不直接反映在产生的剪接变体的改变中,这表明 AS 不能仅由这些顺式元件决定,而应该是由更复杂的调控模式决定的。

相似文献

1
Transcript diversity of Machado-Joseph disease gene (ATXN3) is not directly determined by SNPs in exonic or flanking intronic regions.肌萎缩侧索硬化症基因(ATXN3)的转录本多样性不受外显子或侧翼内含子区域 SNPs 的直接影响。
J Mol Neurosci. 2013 Mar;49(3):539-43. doi: 10.1007/s12031-012-9832-3. Epub 2012 Jun 16.
2
Increased transcript diversity: novel splicing variants of Machado-Joseph disease gene (ATXN3).转录本多样性增加:Machado-Joseph 病基因(ATXN3)的新型剪接变体。
Neurogenetics. 2010 May;11(2):193-202. doi: 10.1007/s10048-009-0216-y. Epub 2009 Aug 28.
3
The genomic structure and expression of MJD, the Machado-Joseph disease gene.马查多-约瑟夫病基因MJD的基因组结构与表达
J Hum Genet. 2001;46(7):413-22. doi: 10.1007/s100380170060.
4
Blood and cerebellar abundance of ATXN3 splice variants in spinocerebellar ataxia type 3/Machado-Joseph disease.脊髓小脑共济失调 3 型/马查多-约瑟夫病中 ATXN3 剪接变异体在血液和小脑中的丰度。
Neurobiol Dis. 2024 Apr;193:106456. doi: 10.1016/j.nbd.2024.106456. Epub 2024 Feb 27.
5
Sequence analysis of 5' regulatory regions of the Machado-Joseph disease gene (ATXN3).Machado-Joseph 病基因(ATXN3)5' 调控区序列分析。
Cerebellum. 2012 Dec;11(4):1045-50. doi: 10.1007/s12311-012-0373-7.
6
The (CAG)n tract of Machado-Joseph Disease gene (ATXN3): a comparison between DNA and mRNA in patients and controls.马查多-约瑟夫病基因 (ATXN3) 的 (CAG)n 重复序列:患者和对照者的 DNA 和 mRNA 比较。
Eur J Hum Genet. 2010 May;18(5):621-3. doi: 10.1038/ejhg.2009.215. Epub 2009 Nov 25.
7
Physiological and pathophysiological characteristics of ataxin-3 isoforms.ATXN3 异构体的生理和病理生理学特征。
J Biol Chem. 2019 Jan 11;294(2):644-661. doi: 10.1074/jbc.RA118.005801. Epub 2018 Nov 19.
8
The role of apolipoprotein E as a risk factor for an earlier age at onset for Machado-Joseph disease is doubtful.载脂蛋白E作为马查多-约瑟夫病发病年龄提前的一个风险因素,其作用尚不确定。
PLoS One. 2014 Nov 4;9(11):e111356. doi: 10.1371/journal.pone.0111356. eCollection 2014.
9
Genetic Variation in ATXN3 (Ataxin-3) 3'UTR: Insights into the Downstream Regulatory Elements of the Causative Gene of Machado-Joseph Disease/Spinocerebellar Ataxia Type 3.ATXN3(ataxin-3)3'非翻译区的遗传变异:对马查多-约瑟夫病/脊髓小脑共济失调3型致病基因下游调控元件的见解。
Cerebellum. 2023 Feb;22(1):37-45. doi: 10.1007/s12311-021-01358-0. Epub 2022 Jan 16.
10
Mouse ataxin-3 functional knock-out model.小鼠共济失调-3 功能敲除模型。
Neuromolecular Med. 2011 Mar;13(1):54-65. doi: 10.1007/s12017-010-8137-3. Epub 2010 Oct 14.

引用本文的文献

1
ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3.ATXN3:一种多功能蛋白,参与多聚谷氨酰胺疾病脊髓小脑共济失调 3 型。
Expert Rev Mol Med. 2024 Sep 25;26:e19. doi: 10.1017/erm.2024.10.
2
The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases.ataxin-3 的去泛素化酶功能及其在 Machado-Joseph 病和其他疾病发病机制中的作用。
Biochem J. 2024 Mar 20;481(6):461-480. doi: 10.1042/BCJ20240017.
3
Physiological and pathophysiological characteristics of ataxin-3 isoforms.

本文引用的文献

1
Sequence analysis of 5' regulatory regions of the Machado-Joseph disease gene (ATXN3).Machado-Joseph 病基因(ATXN3)5' 调控区序列分析。
Cerebellum. 2012 Dec;11(4):1045-50. doi: 10.1007/s12311-012-0373-7.
2
The APOE ε2 allele increases the risk of earlier age at onset in Machado-Joseph disease.APOE ε2等位基因会增加马查多-约瑟夫病发病年龄提前的风险。
Arch Neurol. 2011 Dec;68(12):1580-3. doi: 10.1001/archneurol.2011.636.
3
Machado-Joseph Disease: from first descriptions to new perspectives.马查多-约瑟夫病:从最初的描述到新视角。
ATXN3 异构体的生理和病理生理学特征。
J Biol Chem. 2019 Jan 11;294(2):644-661. doi: 10.1074/jbc.RA118.005801. Epub 2018 Nov 19.
4
Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice.反义寡核苷酸介导的脊髓小脑共济失调3型小鼠多聚谷氨酰胺重复序列去除
Mol Ther Nucleic Acids. 2017 Sep 15;8:232-242. doi: 10.1016/j.omtn.2017.06.019. Epub 2017 Jun 29.
Orphanet J Rare Dis. 2011 Jun 2;6:35. doi: 10.1186/1750-1172-6-35.
4
RNA splicing: disease and therapy.RNA 剪接:疾病与治疗。
Brief Funct Genomics. 2011 May;10(3):151-64. doi: 10.1093/bfgp/elr020.
5
RNA sequencing reveals the role of splicing polymorphisms in regulating human gene expression.RNA 测序揭示了剪接多态性在调节人类基因表达中的作用。
Genome Res. 2011 Apr;21(4):545-54. doi: 10.1101/gr.111211.110. Epub 2010 Dec 20.
6
RNA-targeted splice-correction therapy for neuromuscular disease.针对神经肌肉疾病的 RNA 靶向剪接校正治疗。
Brain. 2010 Apr;133(Pt 4):957-72. doi: 10.1093/brain/awq002. Epub 2010 Feb 11.
7
The (CAG)n tract of Machado-Joseph Disease gene (ATXN3): a comparison between DNA and mRNA in patients and controls.马查多-约瑟夫病基因 (ATXN3) 的 (CAG)n 重复序列:患者和对照者的 DNA 和 mRNA 比较。
Eur J Hum Genet. 2010 May;18(5):621-3. doi: 10.1038/ejhg.2009.215. Epub 2009 Nov 25.
8
The pathobiology of splicing.剪接的病理生物学。
J Pathol. 2010 Jan;220(2):152-63. doi: 10.1002/path.2649.
9
Increased transcript diversity: novel splicing variants of Machado-Joseph disease gene (ATXN3).转录本多样性增加:Machado-Joseph 病基因(ATXN3)的新型剪接变体。
Neurogenetics. 2010 May;11(2):193-202. doi: 10.1007/s10048-009-0216-y. Epub 2009 Aug 28.
10
Alternative splicing: regulation without regulators.可变剪接:无需调控因子的调控
Nat Struct Mol Biol. 2009 Jan;16(1):13-5. doi: 10.1038/nsmb0109-13.